ProShares Ultra NASDAQ Biotechnology
38 hedge funds and large institutions have $23.3M invested in ProShares Ultra NASDAQ Biotechnology in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 8 closing their positions.
Holders
38
Holders Change
-3
Holders Change %
-7.32%
% of All Funds
0.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
5
Reduced
10
Closed
8
Calls
$8.07M
Puts
$21.4M
Net Calls
-$13.4M
Net Calls Change
-$7.68M